
Golam M. Shameem
Examiner (ID: 11001, Phone: (571)272-0706 , Office: P/1626 )
| Most Active Art Unit | 1621 |
| Art Unit(s) | 1621, 1622, 1626 |
| Total Applications | 3199 |
| Issued Applications | 2366 |
| Pending Applications | 304 |
| Abandoned Applications | 576 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14621821
[patent_doc_number] => 20190224278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => PRODUCING METHOD OF ANTIMICROBIAL PEPTIDE WITH ENHANCED ADHESION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/175640
[patent_app_country] => US
[patent_app_date] => 2018-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5671
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16175640
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/175640 | PRODUCING METHOD OF ANTIMICROBIAL PEPTIDE WITH ENHANCED ADHESION AND USES THEREOF | Oct 29, 2018 | Abandoned |
Array
(
[id] => 16204873
[patent_doc_number] => 20200237863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => Combination Therapy of Fractionated Radiation and SAPC-DOPS for the Treatment of Tumors
[patent_app_type] => utility
[patent_app_number] => 16/756251
[patent_app_country] => US
[patent_app_date] => 2018-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6214
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16756251
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/756251 | Combination Therapy of Fractionated Radiation and SAPC-DOPS for the Treatment of Tumors | Oct 15, 2018 | Abandoned |
Array
(
[id] => 13870773
[patent_doc_number] => 20190031727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => ORAL ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 16/157842
[patent_app_country] => US
[patent_app_date] => 2018-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14113
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16157842
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/157842 | ORAL ADMINISTRATION | Oct 10, 2018 | Abandoned |
Array
(
[id] => 13826545
[patent_doc_number] => 20190016757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => ANTIMICROBIAL PEPTIDES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/145064
[patent_app_country] => US
[patent_app_date] => 2018-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13118
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16145064
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/145064 | Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof | Sep 26, 2018 | Issued |
Array
(
[id] => 17236669
[patent_doc_number] => 11180541
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-23
[patent_title] => Recombinant collagen and elastin molecules and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/144914
[patent_app_country] => US
[patent_app_date] => 2018-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 27977
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16144914
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/144914 | Recombinant collagen and elastin molecules and uses thereof | Sep 26, 2018 | Issued |
Array
(
[id] => 16924066
[patent_doc_number] => 11045522
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-29
[patent_title] => Glucagon-like peptide 1 receptor agonists and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/137662
[patent_app_country] => US
[patent_app_date] => 2018-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14535
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16137662
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/137662 | Glucagon-like peptide 1 receptor agonists and uses thereof | Sep 20, 2018 | Issued |
Array
(
[id] => 15647235
[patent_doc_number] => 20200086147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => COMPOSITION OF DIGESTIVE ENZYMES AND APPETITE SUPPRESSANTS
[patent_app_type] => utility
[patent_app_number] => 16/130394
[patent_app_country] => US
[patent_app_date] => 2018-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4126
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16130394
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/130394 | COMPOSITION OF DIGESTIVE ENZYMES AND APPETITE SUPPRESSANTS | Sep 12, 2018 | Abandoned |
Array
(
[id] => 13733095
[patent_doc_number] => 20180371015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => NEW DIFLUOROKETAMIDE DERIVATIVES AS HTRA1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/121244
[patent_app_country] => US
[patent_app_date] => 2018-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16366
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16121244
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/121244 | Difluoroketamide derivatives as HtrA1 inhibitors | Sep 3, 2018 | Issued |
Array
(
[id] => 13732985
[patent_doc_number] => 20180370960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => Solid Oral Formulations and Crystalline Forms of an Inhibitor of Apoptosis Protein
[patent_app_type] => utility
[patent_app_number] => 16/120073
[patent_app_country] => US
[patent_app_date] => 2018-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9489
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16120073
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/120073 | Solid Oral Formulations and Crystalline Forms of an Inhibitor of Apoptosis Protein | Aug 30, 2018 | Abandoned |
Array
(
[id] => 13603733
[patent_doc_number] => 20180353415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => Peptides and Their Use in The Treatment of Hair
[patent_app_type] => utility
[patent_app_number] => 16/106503
[patent_app_country] => US
[patent_app_date] => 2018-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12198
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16106503
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/106503 | Peptides and Their Use in The Treatment of Hair | Aug 20, 2018 | Abandoned |
Array
(
[id] => 13604061
[patent_doc_number] => 20180353579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => Maspin, Maspin Derivatives, and Maspin Mimetics for Reducing ROS, Inflammation, and Skin Aging
[patent_app_type] => utility
[patent_app_number] => 16/104751
[patent_app_country] => US
[patent_app_date] => 2018-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8623
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16104751
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/104751 | Maspin, Maspin Derivatives, and Maspin Mimetics for Reducing ROS, Inflammation, and Skin Aging | Aug 16, 2018 | Abandoned |
Array
(
[id] => 14273853
[patent_doc_number] => 20190134211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => CAR PEPTIDE FOR HOMING, DIAGNOSIS & TARGETED THERAPY FOR PULMONARY AND FIBROTIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/057696
[patent_app_country] => US
[patent_app_date] => 2018-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8854
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16057696
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/057696 | CAR PEPTIDE FOR HOMING, DIAGNOSIS & TARGETED THERAPY FOR PULMONARY AND FIBROTIC DISORDERS | Aug 6, 2018 | Abandoned |
Array
(
[id] => 14273751
[patent_doc_number] => 20190134160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => Pharmaceutical Combination for Use in Glycemic Control in Diabetes Type 2 Patients
[patent_app_type] => utility
[patent_app_number] => 16/038733
[patent_app_country] => US
[patent_app_date] => 2018-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19128
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16038733
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/038733 | Pharmaceutical Combination for Use in Glycemic Control in Diabetes Type 2 Patients | Jul 17, 2018 | Abandoned |
Array
(
[id] => 13522039
[patent_doc_number] => 20180312562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => WATER SOLUBLE MEMBRANE PROTEINS AND METHODS FOR THE PREPARATION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/034549
[patent_app_country] => US
[patent_app_date] => 2018-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6378
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -85
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16034549
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/034549 | WATER SOLUBLE MEMBRANE PROTEINS AND METHODS FOR THE PREPARATION AND USE THEREOF | Jul 12, 2018 | Abandoned |
Array
(
[id] => 13551863
[patent_doc_number] => 20180327479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => Factor VIII Variants Having A Decreased Cellular Uptake
[patent_app_type] => utility
[patent_app_number] => 16/028603
[patent_app_country] => US
[patent_app_date] => 2018-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20150
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16028603
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/028603 | Factor VIII variants having a decreased cellular uptake | Jul 5, 2018 | Issued |
Array
(
[id] => 15866229
[patent_doc_number] => 20200140518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => RAGE PROTEINS FOR THE TREATMENT OF FIBROSIS AND DNA DAMAGE MEDIATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 16/625212
[patent_app_country] => US
[patent_app_date] => 2018-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15957
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16625212
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/625212 | RAGE PROTEINS FOR THE TREATMENT OF FIBROSIS AND DNA DAMAGE MEDIATED DISEASES | Jun 21, 2018 | Abandoned |
Array
(
[id] => 18413153
[patent_doc_number] => 11667686
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-06
[patent_title] => Erythropoietin and analogs for veterinary use
[patent_app_type] => utility
[patent_app_number] => 16/617380
[patent_app_country] => US
[patent_app_date] => 2018-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 22
[patent_no_of_words] => 25185
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16617380
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/617380 | Erythropoietin and analogs for veterinary use | Jun 4, 2018 | Issued |
Array
(
[id] => 14018953
[patent_doc_number] => 20190071470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => ANTIMICROBIAL PEPTIDES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/000709
[patent_app_country] => US
[patent_app_date] => 2018-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8696
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16000709
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/000709 | ANTIMICROBIAL PEPTIDES AND METHODS OF USE THEREOF | Jun 4, 2018 | Abandoned |
Array
(
[id] => 13440897
[patent_doc_number] => 20180271991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
[patent_app_type] => utility
[patent_app_number] => 15/996612
[patent_app_country] => US
[patent_app_date] => 2018-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24333
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15996612
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/996612 | CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS | Jun 3, 2018 | Abandoned |
Array
(
[id] => 14372461
[patent_doc_number] => 20190160143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => ANTIBACTERIAL COMPOSITION COMPRISING MICROCIN S AND ANTIBIOTIC
[patent_app_type] => utility
[patent_app_number] => 15/989790
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5447
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15989790
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/989790 | ANTIBACTERIAL COMPOSITION COMPRISING MICROCIN S AND ANTIBIOTIC | May 24, 2018 | Abandoned |